Anti-MDA5 DM and coronavirus disease 2019 (COVID-19) share several common features, clinical and pathogenic, and exploring the pathophysiological mechanisms of COVID-19 may help to better understand the pathogenesis of anti-MDA5 DM (147). Here, IFIH1 is linked to COVID-19.